(Q33777487)

29 July 2017

1 reference

title

Endovascular therapy for aneurysmal vasospasm (English)

1 reference

29 July 2017

Newell DW

1

1 reference

29 July 2017

Elliott JP

series ordinal

2

1 reference

29 July 2017

Eskridge JM

series ordinal

3

1 reference

29 July 2017

Winn HR

series ordinal

4

1 reference

29 July 2017

publication date

1 October 1999

1 reference

29 July 2017

published in

Critical Care Clinics

1 reference

29 July 2017

volume

15

1 reference

29 July 2017

issue

4

1 reference

29 July 2017

page(s)

685-99, v

1 reference

Clinical vasospasm after subarachnoid hemorrhage: response to hypervolemic hemodilution and arterial hypertension

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970082-8

7 January 2021

Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: a metaanalysis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970082-8

7 January 2021

The efficacy and safety of angioplasty for cerebral vasospasm after subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970082-8

7 January 2021

Comparison of balloon angioplasty and papaverine infusion for the treatment of vasospasm following aneurysmal subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970082-8

7 January 2021

Balloon angioplasty for the treatment of vasospasm: results of first 50 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970082-8

7 January 2021

Endovascular treatment of vasospasm.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970082-8

7 January 2021

Improvement of cerebral oxygenation patterns and metabolic validation of superselective intraarterial infusion of papaverine for the treatment of cerebral vasospasm.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970082-8

7 January 2021

Calcium antagonists in patients with aneurysmal subarachnoid hemorrhage: a systematic review.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970082-8

7 January 2021

Effect of transluminal angioplasty on cerebral blood flow in the management of symptomatic vasospasm following aneurysmal subarachnoid hemorrhage.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970082-8

7 January 2021

Balloon angioplasty immediately after surgical clipping for symptomatic vasospasm on admission. Report of four cases

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970082-8

7 January 2021

A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in North America

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970082-8

7 January 2021

Cerebral vasospasm after subarachnoid hemorrhage: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970082-8

7 January 2021

Transluminal angioplasty for treatment of intracranial arterial vasospasm

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970082-8

7 January 2021

Intravascular balloon dilatation therapy for intracranial arterial vasospasm: patient selection, technique, and clinical results

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970082-8

7 January 2021

Superselective intra-arterial infusion of papaverine for the treatment of cerebral vasospasm after subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970082-8

7 January 2021

Treatment of cerebral vasospasm with intra-arterial papaverine

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970082-8

7 January 2021

Reversal of acute ischemic hypodense lesions on computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970082-8

7 January 2021

Histological studies of intracranial vessels in primates following transluminal angioplasty for vasospasm

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970082-8

7 January 2021

Severe symptomatic vasospasm: the role of immediate postoperative angioplasty.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970082-8

7 January 2021

Angioplasty reduces pharmacologically mediated vasoconstriction in rabbit carotid arteries with and without vasospasm

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970082-8

7 January 2021

Technical considerations on intra-arterial papaverine hydrochloride for cerebral vasospasm

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970082-8

7 January 2021

Intracranial pressure changes induced during papaverine infusion for treatment of vasospasm

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970082-8

7 January 2021

In vivo angioplasty prevents the development of vasospasm in canine carotid arteries. Pharmacological and morphological analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970082-8

7 January 2021

Increase in diameters of vasospastic intracranial arteries by intraarterial papaverine administration

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970082-8

7 January 2021

Angioplasty for the treatment of symptomatic vasospasm following subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970082-8

7 January 2021

Cerebral vasospastic vessels: histologic changes after percutaneous transluminal angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970082-8

7 January 2021

Cerebral vasospasm evaluated by transcranial ultrasound correlated with clinical grade and CT-visualized subarachnoid hemorrhage.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970082-8

7 January 2021

Transcranial Doppler detection of vertebrobasilar vasospasm following subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970082-8

7 January 2021

Sensitivity and specificity of transcranial Doppler ultrasonography in the diagnosis of vasospasm following subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970082-8

7 January 2021

Attempted prevention or treatment of intracranial arterial spasm: a survey

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970082-8

7 January 2021

Mechanism of action of balloon angioplasty in cerebral vasospasm

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970082-8

7 January 2021

Determination of irreversible ischemia by xenon-enhanced computed tomographic monitoring of cerebral blood flow in patients with symptomatic vasospasm.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970082-8

7 January 2021

Angioplasty of vasospasm: is it reasonable?

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970082-8

7 January 2021

Balloon catheter technique for dilatation of constricted cerebral arteries after aneurysmal SAH

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970082-8

7 January 2021

10.1016/S0749-0704(05)70082-8

Identifiers

DOI

1 reference

29 July 2017

1 reference